Examining the Efficacy of a Virtual Reality Cognitive Remediation Program for People Living With Psychosis

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Individuals living with a psychotic disorder often experience changes to their thinking and social skills that can lead to challenges with work, school, relationships and living independently. One intervention to target these areas is cognitive remediation therapy, which can be delivered in virtual reality to help apply the skills and strategies learned to day-to-day life. Over the past few years, our team has co-developed a cognitive remediation program in virtual reality with healthcare professionals and people with lived experiences of psychosis. The current trial tests the feasibility and efficacy of this cognitive remediation program in virtual reality at improving thinking skills, social skills, and daily life functioning.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 20
Maximum Age: 55
Healthy Volunteers: f
View:

• Diagnosis of a psychosis-spectrum disorder

• Equal or between 20 to 55 years old

• Ability to read and speak English

• Be clinically stable, as defined as a total Positive And Negative Severity Symptoms score equal or between 30 - 95

• No changes to their medication dosage, starting a new medication, or stopping a medication within the past month before signing the consent form

Locations
Other Locations
Canada
Royal Ottawa Mental Health Centre
RECRUITING
Ottawa
Contact Information
Primary
Synthia Guimond, PhD
synthia.guimond@theroyal.ca
613-722-6521
Time Frame
Start Date: 2023-07-31
Estimated Completion Date: 2026-02
Participants
Target number of participants: 52
Treatments
Experimental: Cognitive Remediation
Active_comparator: Active Control
Related Therapeutic Areas
Sponsors
Collaborators: Fonds de la Recherche en Santé du Québec, The Royal's Institute of Mental Health Research
Leads: The Royal Ottawa Mental Health Centre

This content was sourced from clinicaltrials.gov